Drug
Fordadistrogene Movaparvovec
Fordadistrogene Movaparvovec: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| fordadistrogene movaparvovec NCT05689164 | Phase 3 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Fordadistrogene Movaparvovec on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.